Tang Capital Management LLC Astria Therapeutics, Inc. Transaction History
Tang Capital Management LLC
- $1.17 Billion
- Q3 2024
A detailed history of Tang Capital Management LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 100,000 shares of ATXS stock, worth $763,000. This represents 0.09% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$763,000
Previous $910,000
20.99%
% of portfolio
0.09%
Previous 0.11%
Shares
1 transactions
Others Institutions Holding ATXS
# of Institutions
108Shares Held
48.6MCall Options Held
48KPut Options Held
9.3K-
Perceptive Advisors LLC New York, NY6.49MShares$49.5 Million1.87% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.11MShares$39 Million0.78% of portfolio
-
Vestal Point Capital, LP New York, NY4MShares$30.5 Million3.34% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$27.1 Million6.36% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$26.8 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $116M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...